Pharmaceuticals chemical synthesis

Proteases Proteins Proteolysis Detergents, food, pharmaceutical, chemicals synthesis... 

There are, however, numerous appHcations forthcoming ia medium- to small-scale processiag. Especially attractive on this scale is the pharmaceutical fine chemical or high value added chemical synthesis (see Fine chemicals). In these processes multistep reactions are common, and an electroorganic reaction step can aid ia process simplification. Off the shelf lab electrochemical cells, which have scaled-up versions, are also available. The materials of constmction for these cells are compatible with most organic chemicals. 

The second most important group of immobilized enzymes is stiU the penicillin G and V acylases. These are used in the pharmaceutical industry to make the intermediate 6-aminopenici11anic acid [551-16-6] (6-APA), which in turn is used to manufacture semisynthetic penicillins, in particular ampicilHn [69-53-4] and amoxicillin [26787-78-0]. This is a remarkable example of how a complex chemical synthesis can be replaced with a simple enzymatic one ... 

Chemistry, Pharmaceutical. 3. Drugs—Chemical synthesis. QV 744 L473o 1977]... 

Besides their essential roles in nature, isoprenoids are of commercial importance in industry. Some isoprenoids have been used as flavors, fragrances, spices, and food additives, while many are used as pharmaceuticals to treat an array of human diseases, such as cancer (Taxol), malaria (artemisinin), and HIV (coumarins). In contrast to the huge market demand, isoprenoids are present only in low abundance in their host organisms. Thus, isolation of the required isoprenoids consumes a large quantity of natural resources. Furthermore, owing to their structural complexity, total chemical synthesis is often not commercially feasible. For these reasons, metabolic engineering may provide an alternative to produce these valuable isoprenoids [88,89]. 

Used industrially as an intermediate in the manufacture of chloroacetophenone, herbicides, pharmaceuticals, and organic chemical synthesis. 

In addition to chemical-based drugs, a range of pharmaceutical substances (e.g. hormones and blood products) are produced by/extracted from biological sources. Such products, some major examples of which are listed in Table 1.2, may thus be described as products of biotechnology. In some instances, categorizing pharmaceuticals as products of biotechnology or chemical synthesis becomes somewhat artificial. For example, certain semi-synthetic antibiotics are produced by chemical modification of natural antibiotics produced by fermentation technology. 

Table 1.1 Some traditional pharmaceutical substances that are generally produced by direct chemical synthesis...

The medical success of these drugs gave new emphasis to the pharmaceutical industry, which was boosted further by the commencement of industrial-scale penicillin manufacture in the early 1940s. Around this time, many of the current leading pharmaceutical companies (or their forerunners) were founded. Examples include Ciba Geigy, Eli Lilly, Wellcome, Glaxo and Roche. Over the next two to three decades, these companies developed drugs such as tetracyclines, corticosteroids, oral contraceptives, antidepressants and many more. Most of these pharmaceutical substances are manufactured by direct chemical synthesis. 

The use of molecular wires and devices for electronics applications is destined to occur. The ability to control molecular structures at the subnanometer scale is obvious throughout chemical synthesis. These are the same techniques that have been optimized over the last 50 years for the synthesis and modification of compounds for pharmaceutical, dye, petroleum, and fine chemical indus-... 

The ACS GCI Pharmaceutical Roundtable recently set out to prioritize the areas of chemical synthesis where unproved methodology would realize the greatest beneficial impact on pharmaceutical production. This resulted in the publication of a wish list of currently utilized transformations that require better reagents and aspirational transformations that would provide shorter routes were they available (Table 1.3). ... 

---